The human microbiome and bile acid metabolism: dysbiosis, dysmetabolism, disease and intervention. (Q38183448)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24479734%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

title

The human microbiome and bile acid metabolism: dysbiosis, dysmetabolism, disease and intervention (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24479734%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

0 references

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24479734%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

author name string

Mitchell L Jones

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24479734%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Christopher J Martoni

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24479734%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Jorge G Ganopolsky

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24479734%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Alain Labbé

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24479734%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

language of work or name

English

0 references

publication date

30 January 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24479734%20AND%20SRC:MED&resulttype=core&format=json

Expert Opinion on Biological Therapy

6 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24479734%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

volume

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24479734%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24479734%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

page(s)

467-482

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24479734%20AND%20SRC:MED&resulttype=core&format=json

Host-bacterial mutualism in the human intestine

6 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.880420

Ecological and evolutionary forces shaping microbial diversity in the human intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.880420

The human microbiome project

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.880420

The gut flora as a forgotten organ

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.880420

Prokaryotes: the unseen majority

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.880420

Polysaccharide utilization by gut bacteria: potential for new insights from genomic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.880420

Glycan foraging in vivo by an intestine-adapted bacterial symbiont

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.880420

Bacteria as vitamin suppliers to their host: a gut microbiota perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.880420

Effects of probiotics and commensals on intestinal epithelial physiology: implications for nutrient handling

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.880420

ComPPARtmentalizing NF-kappaB in the gut.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.880420

Role of the commensal microbiota in normal and pathogenic host immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.880420

Host-microbe interactions that facilitate gut colonization by commensal bifidobacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.880420

Genetically dictated change in host mucus carbohydrate landscape exerts a diet-dependent effect on the gut microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.880420

Organismal, genetic, and transcriptional variation in the deeply sequenced gut microbiomes of identical twins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.880420

Enterotypes of the human gut microbiome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.880420

Succession of microbial consortia in the developing infant gut microbiome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.880420

Composition, variability, and temporal stability of the intestinal microbiota of the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.880420

Linking long-term dietary patterns with gut microbial enterotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.880420

Bacterial colonization factors control specificity and stability of the gut microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.880420

The impact of the gut microbiota on human health: an integrative view

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.880420

The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.880420

Microbial ecology: human gut microbes associated with obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.880420

Gut microbiota disturbance during antibiotic therapy: a multi-omic approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.880420

Diet-induced dysbiosis of the intestinal microbiota and the effects on immunity and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.880420

TGR5-mediated bile acid sensing controls glucose homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.880420

Targeting bile-acid signalling for metabolic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.880420

Pleiotropic roles of bile acids in metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.880420

Serum bile acids are higher in humans with prior gastric bypass: potential contribution to improved glucose and lipid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.880420

Roux-en-Y gastric bypass normalizes the blunted postprandial bile acid excursion associated with obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.880420

Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss: links with metabolic and low-grade inflammation markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.880420

Metagenomic sequencing of the human gut microbiome before and after bariatric surgery in obese patients with type 2 diabetes: correlation with inflammatory and metabolic parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.880420

Potential of surgery for curing type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.880420

Bile salt biotransformations by human intestinal bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.880420

Functional and comparative metagenomic analysis of bile salt hydrolase activity in the human gut microbiome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.880420

Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.880420

Bile acids regulate cardiovascular function

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.880420

The bile acid receptor FXR is a modulator of intestinal innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.880420

Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.880420

Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.880420

Increase in fecal primary bile acids and dysbiosis in patients with diarrhea-predominant irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.880420

The role of the gut microbiota in energy metabolism and metabolic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.880420

Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.880420

Crosstalk between the gut microbiota and the endocannabinoid system: impact on the gut barrier function and the adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.880420

Inflammatory mechanisms in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.880420

Correcting vitamin D insufficiency improves insulin sensitivity in obese adolescents: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.880420

Effect of the Mediterranean diet with and without weight loss on markers of inflammation in men with metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.880420

Richness of human gut microbiome correlates with metabolic markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.880420

An obesity-associated gut microbiome with increased capacity for energy harvest

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.880420

Gut microbiota from twins discordant for obesity modulate metabolism in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.880420

Dietary intervention impact on gut microbial gene richness

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.880420

Mechanisms of beta-cell death in type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.880420

Host remodeling of the gut microbiome and metabolic changes during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.880420

Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.880420

Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.880420

A metagenome-wide association study of gut microbiota in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.880420

Bile acids promote glucagon-like peptide-1 secretion through TGR5 in a murine enteroendocrine cell line STC-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.880420

Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.880420

Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.880420

Symptomatic atherosclerosis is associated with an altered gut metagenome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.880420

Human oral, gut, and plaque microbiota in patients with atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.880420

Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.880420

Chronic Chlamydia pneumoniae Infection as a Risk Factor for Coronary Heart Disease in the Helsinki Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.880420

Association between dental health and acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.880420

Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.880420

Modulation of atherosclerosis in mice by Toll-like receptor 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.880420

Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.880420

Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.880420

Bifidobacterium animalis strain DN-173 010 hydrolyses bile salts in the gastrointestinal tract of pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.880420

Effect of antimicrobial agents on the ecological balance of human microflora

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.880420

Administration of ampicillin elevates hepatic primary bile acid synthesis through suppression of ileal fibroblast growth factor 15 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.880420

The association of bile acid excretion and atherosclerotic coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.880420

Bile acid metabolites in serum: intraindividual variation and associations with coronary heart disease, metabolic syndrome and diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.880420

Enteric microbiome metabolites correlate with response to simvastatin treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.880420

The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.880420

Composition and temporal stability of gastrointestinal microbiota in irritable bowel syndrome--a longitudinal study in IBS and control subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.880420

Acute gastroenteritis is followed by an increased risk of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.880420

Increased short- and long-term risk of inflammatory bowel disease after salmonella or campylobacter gastroenteritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.880420

Diet, microbes, and host genetics: the perfect storm in inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.880420

Dysbiosis modulates capacity for bile acid modification in the gut microbiomes of patients with inflammatory bowel disease: a mechanism and marker of disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.880420

A human gut microbial gene catalogue established by metagenomic sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.880420

Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.880420

Twin study indicates loss of interaction between microbiota and mucosa of patients with ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.880420

AGA technical review on irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.880420

Effect of bile acid perfusion on colonic motor function in patients with the irritable colon syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.880420

Bile acids and colonic motility in the rabbit and the human

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.880420

Colonic secretion of water and electrolytes induced by bile acids: perfusion studies in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.880420

Association of bile acid receptor TGR5 variation and transit in health and lower functional gastrointestinal disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.880420

Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.880420

Probiotic use decreases intestinal inflammation and increases bone density in healthy male but not female mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.880420

Letter to the editor regarding the report of Duboc et al: Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.880420

Live Lactobacillus rhamnosus [corrected] is essential for the inhibitory effect on tumor necrosis factor alpha-induced interleukin-8 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.880420

Lactobacillus reuteri CRL1098 soluble factors modulate tumor necrosis factor alpha production in peripheral blood mononuclear cells: involvement of lipid rafts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.880420

Association between bile acid turnover and osteoporosis in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.880420

Vitamin D-3 intestinal absorption in vivo: influence of fatty acids, bile salts, and perfusate pH on absorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.880420

Oral supplementation with probiotic L. reuteri NCIMB 30242 increases mean circulating 25-hydroxyvitamin D: a post hoc analysis of a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.880420

Gut microbiota, probiotics, and vitamin D: interrelated exposures influencing allergy, asthma, and obesity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.880420

Probiotics, nuclear receptor signaling, and anti-inflammatory pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.880420

Novel potent and selective bile acid derivatives as TGR5 agonists: biological screening, structure-activity relationships, and molecular modeling studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.880420

Functional characterization of the semisynthetic bile acid derivative INT-767, a dual farnesoid X receptor and TGR5 agonist.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.880420

Effect of bile acid sequestrants on glucose metabolism, hepatic de novo lipogenesis, and cholesterol and bile acid kinetics in type 2 diabetes: a randomised controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.880420

Bile acid metabolism and the pathogenesis of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.880420

Metabolic profiling of the human response to a glucose challenge reveals distinct axes of insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.880420

Enterobacteria-mediated deconjugation of taurocholic acid enhances ileal farnesoid X receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.880420

Improvement of gastrointestinal health status in subjects consuming Lactobacillus reuteri NCIMB 30242 capsules: a post-hoc analysis of a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.880420